| |
| |
|
| Insider
Information: |
Alton Gregg H |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,846 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,731,983 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,846 |
|
|
| Total
Value |
$3,731,983 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-09-01 |
4 |
AS |
$63.13 |
$225,704 |
D/D |
(3,550) |
24,936 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2007-01-03 |
4 |
AS |
$63.63 |
$229,375 |
D/D |
(3,550) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-08-17 |
4 |
AS |
$64.05 |
$228,014 |
D/D |
(3,550) |
28,486 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-12-01 |
4 |
AS |
$64.25 |
$230,610 |
D/D |
(3,550) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-10-02 |
4 |
AS |
$64.35 |
$230,102 |
D/D |
(3,550) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-06-01 |
4 |
AS |
$65.02 |
$325,114 |
D/D |
(5,000) |
107,988 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-09-27 |
4 |
AS |
$67.00 |
$160,800 |
D/D |
(2,400) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-10-12 |
4 |
AS |
$67.00 |
$80,400 |
D/D |
(1,200) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-12-04 |
4 |
AS |
$67.00 |
$80,400 |
D/D |
(1,200) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-11-01 |
4 |
AS |
$67.26 |
$190,100 |
D/D |
(2,800) |
26,345 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-10-01 |
4 |
AS |
$67.34 |
$1,488,579 |
D/D |
(22,000) |
36,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-03-30 |
4 |
S |
$67.48 |
$337,392 |
D/D |
(5,000) |
117,988 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-11-01 |
4 |
AS |
$67.75 |
$1,491,598 |
D/D |
(22,000) |
35,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-11-01 |
4 |
AS |
$68.21 |
$133,912 |
D/D |
(1,950) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-05-01 |
4 |
AS |
$68.31 |
$341,529 |
D/D |
(5,000) |
112,988 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2019-02-06 |
4 |
D |
$68.75 |
$402,944 |
D/D |
(5,861) |
57,716 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2007-03-01 |
4 |
AS |
$69.40 |
$333,763 |
D/D |
(4,750) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2007-02-01 |
4 |
AS |
$69.90 |
$1,448,192 |
D/D |
(20,650) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-11-20 |
4 |
AS |
$70.00 |
$7,000 |
D/D |
(100) |
24,395 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$462,429 |
D/D |
(6,577) |
124,418 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2013-11-01 |
4 |
AS |
$70.79 |
$2,123,708 |
D/D |
(30,000) |
38,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-07-03 |
4 |
AS |
$71.06 |
$355,295 |
D/D |
(5,000) |
102,988 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2018-01-02 |
4 |
AS |
$72.34 |
$1,108,019 |
D/D |
(15,000) |
49,613 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2014-04-01 |
4 |
AS |
$73.17 |
$951,640 |
D/D |
(13,000) |
132,694 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-07-21 |
4 |
AS |
$74.00 |
$2,960,000 |
D/D |
(40,000) |
97,488 |
0 |
- |
|
360 Records found
|
|
Page 12 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
